Bioanalytical Systems, Inc. (BASI) financial statements (2021 and earlier)

Company profile

Business Address 2701 KENT AVE
WEST LAFAYETT, IN 47906-1382
State of Incorp. IN
Fiscal Year End September 30
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1111000
Cash and cash equivalents1111000
Receivables9974323
Inventory, net of allowances, customer advances and progress billings1111111
Inventory1111111
Prepaid expense3211111
Other undisclosed current assets2221111
Total current assets:1615128557
Noncurrent Assets
Finance lease, right-of-use asset55 
Operating lease, right-of-use asset44 
Nontrade receivables000000 
Property, plant and equipment29292317151616
Intangible assets, net (including goodwill)8966001
Goodwill4443001
Intangible assets, net (excluding goodwill)4433   
Regulated entity, other noncurrent assets     00
Deferred income tax assets  0
Other noncurrent assets0000000
Other undisclosed noncurrent assets   0   
Total noncurrent assets:47463023151617
TOTAL ASSETS:63624231202124
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5685345
Accounts payable4353233
Accrued liabilities2332112
Taxes payable    000
Deferred revenue 117
Debt121111041
Derivative instruments and hedges, liabilities     00
Restructuring reserve000111 
Customer advances and deposits333
Other undisclosed current liabilities18325 10
Total current liabilities:353217128139
Noncurrent Liabilities
Long-term debt and lease obligation2122149404
Long-term debt, excluding current maturities17191494 4
Finance lease, liability00 
Capital lease obligations0000
Operating lease, liability33 
Liabilities, other than long-term debt00    0
Deferred income tax liabilities00 
Derivative instruments and hedges, liabilities      0
Other undisclosed noncurrent liabilities  0    
Total noncurrent liabilities:2122149404
Total liabilities:55543120121413
Stockholders' equity
Stockholders' equity attributable to parent7811118711
Preferred stock0000111
Common stock3333222
Additional paid in capital27272525212121
Accumulated other comprehensive income (loss)     (0)0
Accumulated deficit(22)(22)(17)(16)(16)(17)(14)
Total stockholders' equity:7811118711
TOTAL LIABILITIES AND EQUITY:63624231202124

Income statement (P&L) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Revenues65604426242023
Revenue, net242023
Cost of revenue
(Cost of Goods and Services Sold)
(45)(42)(31)(18)(17)(16)(15)
Gross profit:2118138847
Operating expenses(23)(21)(13)(8)(6)(7)(7)
Operating income (loss):(2)(3)(0)01(3)1
Nonoperating income0000000
Gain on contract termination      0
Other nonoperating income0000000
Interest and debt expense(2)(1)(1)(0)(0)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes     00
Income (loss) from continuing operations before income taxes:(4)(5)(1)(0)1(3)1
Income tax expense (benefit)(0)(0)(0)0(0)0(0)
Income (loss) before gain (loss) on sale of properties:(4)(5)(1)(0)1(3)1
Other undisclosed net loss   (0)   
Net income (loss):(4)(5)(1)(0)1(3)1
Other undisclosed net income attributable to parent   0   
Net income (loss) available to common stockholders, basic:(4)(5)(1)(0)1(3)1
Dilutive securities, effect on basic earnings per share      (0)
Net income (loss) available to common stockholders, diluted:(4)(5)(1)(0)1(3)1

Comprehensive Income ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Net income (loss):(4)(5)(1)(0)1(3)1
Comprehensive income (loss):(4)(5)(1)(0)1(3)1
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   00(0)0
Comprehensive income (loss), net of tax, attributable to parent:(4)(5)(1)(0)1(3)1

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: